Upstream Metabolics, Inc. — SEC Form D Filing

Upstream Metabolics, Inc. filed an SEC Form D on September 29, 2026, reporting $50K raised in Other Health Care.

Form D filing details

Filing
SEC Form D
Filing date
September 29, 2026
Amount reported
$50K
Round stage
Pre-seed, as a fifty-thousand-dollar SAFE raise represents an initial friends-and-family or incubator round to secure early intellectual property.
Industry
Other Health Care
Website
https://upstreammetabolics.com

What the company does

Securities: Simple Agreement for Future Equity (SAFE). Revenue: No Revenues. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Biopharmaceutical researchers and clinicians lack precise tools to identify and target early-stage metabolic pathway dysfunctions before they manifest as chronic systemic diseases.

Solution

Upstream Metabolics develops advanced metabolic profiling assays and software to map early-stage cellular metabolic pathways for targeted therapeutic discovery.

Why now

Recent breakthroughs in high-throughput metabolomics and machine learning-driven pathway analysis have made it commercially viable to map complex cellular metabolic interactions at unprecedented resolution.

Source: SEC EDGAR Form D filing